The work described here includes an original genetic demonstration of the importance of PARP trapping in the single agent activity of PARPi in HRR-deficient cancer cells, while introducing important insights that can inform the development of future PARPi-associated therapeutic strategies. This evidence concerns the gene PARP1 and cancer.